RELAYR/ECOSPRAY
18.2.2021 13:56:06 CET | Business Wire | Press release
Ecospray, a company specializing in the research and development of cutting-edge systems for controlling air and gas emissions in industrial applications for the Maritime industry, has chosen relayr, a leading industrial IoT company based in Berlin, to create new IoT-based desulphurization solutions, driving the sector towards an increasingly digital, efficient and environmentally sustainable future.
The Maritime Industry has been one of the latest in addressing the need to reduce its environmental impact. Now, with the introduction of IMO regulations aimed at reducing sulphur oxide emissions - which came into force in January 2020 - the industry is facing a rising pressure to comply with more stringent environmental regulations, as well as the need of containing costs and improve efficiency in an increasingly competitive and unpredictable market.
In this context, fleets can resort to various solutions, including the installation of scrubbers to remove SOx emissions, or using alternative fuels such as very-low-sulphur fuel oil (VLSFO) but with significantly higher costs compared to bunker fuel.
To meet these market challenges while aiming at developing new solutions capable of radically renewing the entire maritime transport sector, Ecospray has chosen to collaborate with relayr , a company specializing in IoT solutions oriented for business outcomes. The partnership between the two companies will allow the creation of a new generation of emission control equipment: smart scrubbers managed using artificial intelligence, a completely new solution for the market.
Ecospray, market leader in marine emission purification systems (EGCS), has always been committed to developing technological solutions for the maritime sector that can make the processes of reducing the pollutants in the gases produced by ships more efficient. The integrated technologies offered by Ecospray aim at reducing emissions and saving fuel, leading ship owners on the path towards decarbonization of the sector and encouraging the use of clean energy. Part of Carnival Group since 2013, the Italian company has continued to grow in recent years by increasingly specializing in offerings for the marine segment.
"Being part of Carnival Corporation has given us the opportunity to implement high-performance and reliable technological solutions in record time. We were enabled to gain experience across the entire fleet and unparalleled sailing experience, which has allowed us to build robust and use case specific innovations at speed," said Stefano Di Santo, CEO of Ecospray.
The new IMO-compliant devices are not only an innovation that drives an environmentally intensive industry towards a more sustainable future but also an investment that will significantly reduce equipment-running costs for shipbuilders.
The integration of relayr’s IIoT and AI offering tailored to the devices allows to guarantee constant compliance with IMO regulations for the containment of air pollution in the maritime environment. Moreover, it allows significant savings in terms of performance and maintenance through remote monitoring and advanced life cycle analysis. The ability to constantly monitor and analyze the scrubbers’ performance ensures longer equipment life and fuel savings by optimizing pumping operations while also allowing a significant reduction in operating costs.
"We are delighted to collaborate with a company like Ecospray, igniting together the digital transformation of the marine industry," says Josef Brunner, CEO of relayr. "This partnership allows us to enter a new market – bringing high added value with IIoT solutions, helping to exploit the full potential of the control systems machines, and ultimately contributing to the reduction of harmful gas emissions."
“In the maritime industry, a fleet could include hundreds of ships, so the opportunities to build smart machines on such a large scale are literally endless," commented Stefano Di Santo, CEO of Ecospray. "The partnership with relayr allows us to confidently face the challenge of bringing the best of 4.0 technologies to the naval sector. The constant motivation that this project offers us on a daily basis requires a totally different and creative approach to problem solving. I am certain of one thing: together we will never stop improving. Ecospray and relayr: disrupting innovations across the oceans."
The process of digitalization of equipment for gas emission control is only a first step towards a broader business transformation process for the Alessandria-based Ecospray. The visionary approach in collaboration with relayr ultimately envisages the adoption of the Equipment as a Service (EaaS) model. Unlike the traditional asset purchase model, EaaS is based on a pay-per-use offering, in which equipment is no longer purchased but provided in exchange for a usage fee.
Thanks to relayr's experience in implementing the EaaS model, Ecospray will be able to create even more value for its customers, diversifying its revenue streams by offering new services and emerging in the current market scenario.
About Ecospray
From research to development, Ecospray Technologies is specialized in integrated solutions for the green conversion of the maritime and land industries as well as the reduction of dependency on fossil fuels. Founded in 2005 and part of Carnival Group since 2013, Ecospray operates at global level, offering systems aimed at making industrial processes more sustainable through the purification and treatment of pollutants, from emission removal to fuel saving and water filtration. Ecospray's technological solutions leverage three distinctive factors – technology delivered as a service, analysis and use of relevant data, and finance – to facilitate access to innovation and significantly advance the energy transition towards decarbonization and the creation of clean energy.
About relayr
Relayr is the Industrial Internet of Things (IIoT) powerhouse delivering the most complete solutions for risk-free digital transformations. We unleash data insights from existing equipment, machines and production lines to improve our customers’ business outcomes. We enable industrial companies to shift from CAPEX to OPEX-based offerings on their respective markets, providing a unique combination of first-class IIoT technology and its delivery with powerful financial and insurance offerings – all from a single source trusted by hundreds of companies worldwide. With relayr, manufacturers, operators, and service companies for industrial equipment are empowered to implement fully interoperable IIoT solutions guaranteed to achieve their target business outcomes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005584/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom